The Summary
A prospective cohort study of 2,401 clinical patients with suspected obstructive sleep apnea (OSA) investigated how OSA and comorbid insomnia (COMISA) impact all-cause mortality over a six-year follow-up. Using respiratory polygraphy and the Bergen Insomnia Scale, researchers categorized patients by severity. They discovered that moderate-to-severe OSA significantly predicts higher mortality risk. Crucially, when patients suffered from both moderate-to-severe OSA and insomnia, their risk of death tripled (hazard ratio of 3.02) compared to those without, establishing COMISA as a highly dangerous clinical phenotype.
Why this is interesting
Previously, the relationship between sleep apnea and overall mortality was unclear, and insomnia was often treated as a separate, lesser concern. This study reveals that when these two conditions co-occur, they act synergistically to dramatically shorten lifespan. For anyone who snores, gasps for air at night, or struggles to stay asleep, this means seeking a comprehensive diagnosis is critical. Doctors must stop treating these conditions in silos and screen for both, as managing this combined threat is a matter of life and death.